Commission Implementing Regulation (EU) 2025/2272 of 12 November 2025 renewing the approval of the active substance gibberellins as a low-risk active substance in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council and amending Commission Implementing Regulation (EU) No 540/2011

• CELEX: Implementing Regulation (EU) 2025/2272
• Articles: 5

Article 1 Renewal of the approval of the active substance

The approval of the active substance gibberellins, as specified in Annex I to this Regulation, is renewed, subject to the conditions laid down in that Annex.

Article 2 Amendments to Implementing Regulation (EU) No 540/2011

The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with Annex II to this Regulation.

Article 3 Entry into force and date of application

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

It shall apply from 1 January 2026.

Schedules & Appendices

ANNEX I

ANNEX I

Common Name, Identification Numbers

IUPAC Name

Purity  ( 1 )

Date of approval

Expiration of approval

Specific provisions

Gibberellins

CAS No: GA4: 468-44-0

GA7: 510-75-8

GA4/GA7 mixture: 8030-53-3

CIPAC No: 904

GA4: (3S,3aR,4S,4aR,7R,9aR,9bR,12S)-12-hydroxy-3-methyl-6-methylene-2-oxoperhydro-4a,7-methano-3,9b-propanoazuleno[1,2-b]furan-4-carboxylic acid

GA7: (3S,3aR,4S,4aR,7R,9aR,9bR,12S)-12-hydroxy-3-methyl-6-methylene-2-oxoperhydro-4a,7-methano-9b,3-propenoazuleno[1,2-b]furan-4-carboxylic acid

≥ 890 g/kg

The impurities Fumonisins B1 and B2; The sum of fumonisin B1 + fumonisin B2 shall not exceed 200 μg/kg in the technical material.

1 January 2026

31 December 2040

For the implementation of the uniform principles as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the renewal report on gibberellins, and in particular Appendices I and II thereto, shall be taken into account.

Conditions of use shall include risk mitigation measures, where appropriate.

( 1 )   Further details on the identity and specification of the active substance are provided in the renewal report.

ANNEX II

ANNEX II

The Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:

(1)

in Part A, entry 233 on Gibberellins is deleted;

(2)

in Part D, the following entry is added:

No

Common Name, Identification Numbers

IUPAC Name

Purity  ( 1 )

Date of approval

Expiration of approval

Specific provisions

‘56

Gibberellins

CAS No: GA4: 468-44-0

GA7: 510-75-8

GA4/GA7 mixture: 8030-53-3

CIPAC No: 904

GA4: (3S,3aR,4S,4aR,7R,9aR,9bR,12S)-12-hydroxy-3-methyl-6-methylene-2-oxoperhydro-4a,7-methano-3,9b-propanoazuleno[1,2-b]furan-4-carboxylic acid

GA7: (3S,3aR,4S,4aR,7R,9aR,9bR,12S)-12-hydroxy-3-methyl-6-methylene-2-oxoperhydro-4a,7-methano-9b,3-propenoazuleno[1,2-b]furan-4-carboxylic acid

≥ 890 g/kg

The impurities Fumonisins B1 and B2; The sum of fumonisin B1 + fumonisin B2 shall not exceed 200 μg/kg in the technical material.

1 January 2026

31 December 2040

For the implementation of the uniform principles as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the renewal report on gibberellins, and in particular Appendices I and II thereto, shall be taken into account.

Conditions of use shall include risk mitigation measures, where appropriate.’

( 1 )   Further details on the identity and specification of the active substance are provided in the renewal report.